| Produktliste | |||
| API und Zwischenprodukte | |||
| Produktname | CAS-Nr. | Qualität | Bemerkungen |
| 9α-OH-4AD | 560-62-3 | ≥98,5 % | |
| 17α-Hydroxyprogesteron | 604-09-1 | ≥98,0 % | |
| Aciclovir | 59277-89-3 | USP/EP/CP | |
| Amoxicillin-Pulver/verdichtet/mikronisiert | 61336-70-7 | BP+Inhouse | GMP |
| Ambroxolhydrochlorid | 23828-92-4 | USP/BP | GMP |
| Axitinib | 319460-85-0 | ||
| Avatrombopag-Maleat | 677007-74-8 | ||
| Anecohe-Acetat | 7753-60-8 | ≥ 98,5 % | |
| Bendazol HCL | 1212-48-2 | Inhouse | |
| Capmatinib-Hydrochlorid | 1865733-40-9 | ||
| Ceftiofur-Natrium | 104010-37-9 | ||
| Ceftiofurhydrochlorid | 103980-44-5 | ||
| Ceftiofur freie Säure | 80370-57-6 | ||
| Ceftriaxon-Natrium | 74578-69-1 | USP | GMP |
| Cefotaxim-Natrium | 64485-93-4 | USP | GMP |
| Cefquinomsulfat | 118443-89-3 | ||
| Cephalonium | 5575-21-3 | ||
| Ciclopirox | 29342-05-0 | USP/EP | CEP |
| Ciclopirox Olamin | 41621-49-2 | USP/EP/CP | CEP |
| Clozapin | 5786-21-0 | USP/EP | DMF |
| Crizotinib | 877399-52-5 | ||
| Dabrafenib-Mesylat | 1195768-06-9 | ||
| Diczuril | 101831-37-2 | USP/EP/BP | |
| Doremectin | 117704-25-3 | USP/EP/BP | |
| Doxycyclin HCL | 98079-52-8 | USP/EP/BP | |
| Doxofyllin | 69975-86-6 | USP/EP | |
| Edoxabantosylat-Monohydrat | 1229194-11-9 | USP/EP | |
| Entrectinib | 1108743-60-7 | ||
| Famciclovir | 104227-87-4 | USP/CP | KDMF USDMF |
| Finerenon | 1050477-31-0 | ||
| Flunixin-Meglumin | 42461-84-7 | USP | GMP |
| Furaltadon | 139-91-3 | ≥98 % | |
| Furalzolidon | 67-45-8 | USP/EP/BP | |
| Gamithromycin | 145435-72-9 | ||
| Ganciclovir | 82410-32-0 | USP/BP/CP | USDMF EDMF |
| Indapamid | 26807-65-8 | ||
| Inositol Hexanicotiante | 6556-11-2 | USP | |
| Lacosamid | 175481-36-4 | USP/EP | |
| Lenvatinib-Mesylat | 857890-39-2 | ||
| Letermovir | 917389-32-3 | ||
| Loxoprofen-Natrium | 80382-23-6 | ||
| Marbofloxacin | 115550-35-1 | USP | |
| Mobocertinib-Succinat | 2389149-74-8 | ||
| Molnupiravir | 2349386-89-4 | ||
| Naphazolin | 835-31-4 | USP/EP | |
| Neomycinsulfat | 1405-10-3 | USP/BP/EP | |
| Penciclovir | 39809-25-1 | CFDA | KDMF |
| Propofol | 2078-54-8 | USP/EP | |
| Roxadustat | 808118-40-3 | ||
| Safinamidmesylat | 202825-46-5 | ||
| Selpercatinib | 2152628-33-4 | ||
| Streptomycinsulfat | 3810-74-0 | USP/EP | |
| Tenofoviralafenamidfumarat | 1392275-56-7 | ||
| Tiamulin-Wasserstofffumarat | 55297-95-5 | USP/EP | EDMF/FDA |
| Tiamulin HF 80 %/10 % | 55297-95-5 | Inhouse | |
| Tianeptin | 66981-73-5 | ||
| Tilmicosinphosphat | 137330-13-3 | USP/EP/BP | |
| Tylosintartrat | 74610-55-2 | USP/EP/BP | |
| Tylosinphosphat | 1405-53-4 | USP/EP/BP | |
| Tylvalosin | 63409-12-1 | USP/EP | |
| Tucatinib | 937263-43-9 | ||
